Biognosys is a leading provider of next-generation proteomics contract research services and software solutions for pharmaceutical and biotechnology research. The company offers patented proteomics solutions, including Spectronaut software and peptide kits, to support drug discovery, clinical development, and precision medicine.
AI named Biognosys from November 2025 to July 2026.
Brand page for biognosys-com